Patient‐reported outcomes enhance understanding of the impact of pazopanib in soft tissue sarcoma

E-ISSN： 1097-0142|121|17|2868-2870

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.17, 2015-09, pp. : 2868-2870

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Certolizumab Pegol on Patient‐Reported Outcomes in Patients With Axial Spondyloarthritis

ARTHRITIS CARE AND RESEARCH, Vol. 2151-464X, Iss. 10, 2015-10 ,pp. : 1475-1480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Certolizumab Pegol on Patient‐Reported Outcomes in Patients With Axial Spondyloarthritis

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 10, 2015-10 ,pp. : 1475-1480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality of life and patient‐reported outcomes

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 3, 2018-02 ,pp. : 157-158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐Reported Functional and Quality of Life Outcomes in a Large Cohort of Long‐Term Survivors of Ewing Sarcoma

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 12, 2015-12 ,pp. : 2189-2196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Follow‐up of the soft tissue sarcoma patient

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 5, 2015-04 ,pp. : 641-645

John Wiley & Sons Inc

Access to resources Recommend Favorite